Home    About Us    Medic-All    Bio B2B    Hot Topic     Expo     Login | Join Now          
Bio B2BTLC, Ltd. 〉TLC177

TLC177

TLC177

TLC177 is a liposomal encapsulated formulation of Doxorubicin, effectively reducing the side effects of doxorubicin and broadening indications.

Request for Collaboration
Overview
TLC's own formulation of liposome encapsulated doxorubicin effectively reduces the side effects of doxorubicin and broadens  its indications.
Application
Breast cancer / ovarian cancer / Kaposi's sarcoma
Advantages
  • Effectively reduce the side effects of drugs
  • Broadens indications of doxorubicin
People who like this also like
  • PipelinePipeline
  • PipelinePipeline
  • Dynamic Auto-FocusingDynamic Auto-Focusing
  • R&D ManagementR&D Management
  • SB05SB05
  • iSONOiSONO
  • PeptidePeptide
  • Chemistry Manufacturing and Controls (CMC)Chemistry Manufacturing and Controls (CMC)
  • TiMAX Dental ServiceTiMAX Dental Service
  • TAT-HOXB4TAT-HOXB4